Delivery Order SPE2DB22D1017-SPE2DB25FG2PX

Award Date 5/14/25
Potential Completion Date 6/5/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,288.86 and a completion date of March 26, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a Firm Fixed Price Delivery Order contract, and there is no set-aside designation indicated. The contract is part of a larger Indefinite...
This federal contract award is for the delivery of ENVARSUS XR 4 MG TABLET 100S to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,711.95 and is a Firm Fixed Price Delivery Order with a completion date of February 19, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award is for the delivery of ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $2,096.90 and a completion date of December 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This federal contract award is for the delivery of ENVARSUS XR 1 MG TABLET 30S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 13, 2025 for a ceiling value of $1,035.60. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 4, 2025. The contract is not designated as a set-aside. Amerisourcebergen...
This federal contract award is for the procurement of ENVARSUS XR 1 MG TABLET 30S, a pharmaceutical product, by the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $1,165.05 and an ultimate completion date of March 6, 2025. The contract does not have a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENVARSUS XR 4 MG TABLET 100S, a pharmaceutical product, with a ceiling value of $6,847.80 and an ultimate completion date of February 27, 2025. This is a delivery order contract with a firm fixed price pricing type. The contract is not set aside for any specific business designation....
This federal contract award is for the delivery of ENVARSUS XR 4 MG TABLET 100S to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The contract, valued at $1,615.33, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and has an ultimate completion date of December 3, 2024. It is not designated as a set-aside contract....
This federal contract award is for the delivery of ENVARSUS XR 1 MG TABLET 100S to the Defense Logistics Agency (DLA), a defense agency. The $1,216.11 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has an ultimate completion date of August 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of ENVARSUS XR 1 MG TABLET 100S. The award, valued at $1,288.86, is a Firm Fixed Price Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide ENVARSUS XR 4 MG TABLET 100S, a specialty pharmaceutical product, with a ceiling value of $3,230.68. The contract has an ultimate completion date of April 15, 2024. This award is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued up to $999,999,999.00 through...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FG2PX
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of ENVARSUS XR 1 MG TABLET 30S, a pharmaceutical product, to the government. The fixed-price delivery order has a ceiling value of $1,165.05 and a performance period ending on June 5, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and is open to competition. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to supply a wide range of pharmaceutical products and medical supplies to various government agencies, including the Defense Health Agency and U.S. Coast Guard.

Generated 8/13/25, 10:59 AM